{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:38:52Z","timestamp":1770338332392,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,20]],"date-time":"2011-03-20T00:00:00Z","timestamp":1300579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00467-011-1839-4","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T13:29:16Z","timestamp":1300541356000},"page":"195-205","source":"Crossref","is-referenced-by-count":21,"title":["Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations"],"prefix":"10.1007","volume":"27","author":[{"given":"Oluwatoyin","family":"Bamgbola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,20]]},"reference":[{"key":"1839_CR1","doi-asserted-by":"crossref","first-page":"Sii1","DOI":"10.1093\/ndt\/17.suppl_11.1","volume":"19","author":"F Locatelli","year":"2002","unstructured":"Locatelli F, Aljama P, B\u00e1r\u00e1ny P, Canaud B, Carrera F, Eckardt KU, H\u00f6rl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S, European Best Practice Guidelines Working Group (2002) Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19:Sii1\u2013Sii47","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.ajkd.2007.08.013","volume":"50","author":"M Klinger","year":"2007","unstructured":"Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U (2007) Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2\u00a0weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Am J Kidney Dis 50:989\u20131000","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1839_CR3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00467-010-1538-6","volume":"25","author":"MA Atkinson","year":"2010","unstructured":"Atkinson MA, Martz K, Warady BA, Neu AM (2010) Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS 2010. Pediatr Nephrol 25(9):1699\u20131706","journal-title":"Pediatr Nephrol"},{"key":"1839_CR4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/ajkd.2002.34925","volume":"40","author":"LD Wazny","year":"2002","unstructured":"Wazny LD, Stojimirovic BB, Heidenheim P, Blake PG (2002) Factors influencing erythropoietin compliance in peritoneal dialysis patients. Am J Kidney Dis 40:623\u2013628","journal-title":"Am J Kidney Dis"},{"key":"1839_CR5","first-page":"S1","volume":"47","author":"KDOQI","year":"2006","unstructured":"KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S1\u2013S145","journal-title":"Am J Kidney Dis"},{"key":"1839_CR6","first-page":"CD003895","volume":"4","author":"J Cody","year":"2002","unstructured":"Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A (2002) Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database Syst Rev 4:CD003895","journal-title":"Cochrane Database Syst Rev"},{"key":"1839_CR7","first-page":"1379","volume":"61","author":"JJ Irwing","year":"2001","unstructured":"Irwing JJ, Kirchner JT (2001) Anemia in children. Am Fam Physician 61:1379\u20131386","journal-title":"Am Fam Physician"},{"key":"1839_CR8","first-page":"621","volume":"52","author":"M Schoorl","year":"2006","unstructured":"Schoorl M, Schoorl M, Nub\u00e9 MJ, Bartels PC (2006) Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia. Clin Lab 52:621\u2013629","journal-title":"Clin Lab"},{"key":"1839_CR9","first-page":"161","volume":"19","author":"L Gotloib","year":"2006","unstructured":"Gotloib L, Silverberg D, Fudin R, Shostak A (2006) Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol 19:161\u2013167","journal-title":"J Nephrol"},{"key":"1839_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00467-006-0381-2","volume":"23","author":"SM Koshy","year":"2008","unstructured":"Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209\u2013219","journal-title":"Pediatr Nephrol"},{"key":"1839_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.ndt.a027975","volume":"15","author":"DB Wyck Van","year":"2000","unstructured":"Van Wyck DB (2000) Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy. Nephrol Dial Transplant 15:36\u201339","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1523-1755.2001.00800.x","volume":"60","author":"JS Kaufman","year":"2001","unstructured":"Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA (2001) Diagnostic value of iron indices in hemodialysis patients receiving epoetin. Kidney Int 60:300\u2013308","journal-title":"Kidney Int"},{"key":"1839_CR13","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jamda.2006.09.005","volume":"7","author":"AK Agarwal","year":"2007","unstructured":"Agarwal AK (2007) Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc 7:S7\u2013S12","journal-title":"J Am Med Dir Assoc"},{"key":"1839_CR14","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/ndt\/gfl419","volume":"21","author":"D Schiesser","year":"2006","unstructured":"Schiesser D, Binet I, Tsinalis D, Dickenmann M, Keusch G, Schmidli M, Amb\u00fchl PM, L\u00fcthi L, W\u00fcthrich RP (2006) Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrol Dial Transplant 21:2841\u20132845","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/ndt\/16.9.1879","volume":"16","author":"DW Johnson","year":"2001","unstructured":"Johnson DW, Herzig KA, Gissane R, Campbell SB, Hawley CM, Isbel NM (2001) A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrol Dial Transplant 16:1879\u20131884","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR16","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00467-007-0499-x","volume":"22","author":"HE Morgan","year":"2007","unstructured":"Morgan HE, Holt RC, Jones CA, Judd BA (2007) Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin. Pediatr Nephrol 22:1963\u20131965","journal-title":"Pediatr Nephrol"},{"key":"1839_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","volume":"18","author":"DW Coyne","year":"2007","unstructured":"Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR (2007) Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 18:975\u2013984","journal-title":"J Am Soc Nephrol"},{"key":"1839_CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","volume":"19","author":"T Kapoian","year":"2008","unstructured":"Kapoian T, O\u2019Mara NB, Singh AK, Moran J, Rizkala AR, Geronemus R, Kopelman RC, Dahl NV, Coyne DW (2008) Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol 19:372\u2013379","journal-title":"J Am Soc Nephrol"},{"key":"1839_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00467-008-0955-2","volume":"24","author":"RE Port","year":"2009","unstructured":"Port RE, Mehls O (2009) Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit? Pediatr Nephrol 24:435\u2013437","journal-title":"Pediatr Nephrol"},{"key":"1839_CR20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/039139880602900306","volume":"29","author":"P Kalocheretis","year":"2006","unstructured":"Kalocheretis P, Vlamis I, Belesi C, Makriniotou I, Zerbala S, Savidou E, Zorbas S, Arvanitis N, Iatrou C (2006) Residual blood loss in single use dialyzers: effect of different membranes and flux. Int J Artif Organs 29:286\u2013292","journal-title":"Int J Artif Organs"},{"key":"1839_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5414\/CNP58054","volume":"58","author":"F Fabbian","year":"2002","unstructured":"Fabbian F, Catalano C, Bordin V, Balbi T, Di Landro D (2002) Esophagogastroduodenoscopy in chronic hemodialysis patients: 2-year clinical experience in a renal unit. Clin Nephrol 58:54\u201359","journal-title":"Clin Nephrol"},{"issue":"5","key":"1839_CR22","first-page":"481","volume":"8","author":"DE M\u00fcller-Wiefel","year":"1977","unstructured":"M\u00fcller-Wiefel DE, Sinn H, Gilli G, Sch\u00e4rer K (1977) Hemolysis and blood loss in children with chronic renal failure. Clin Nephrol 8(5):481\u2013486","journal-title":"Clin Nephrol"},{"key":"1839_CR23","first-page":"136","volume":"19","author":"K Tomori","year":"2003","unstructured":"Tomori K, Nakamoto H, Kotaki S, Ishida Y, Takane H, Nemoto H, Kanno Y, Sugahara S, Okada H, Suzuki H (2003) Gastric angiodysplasia in patients undergoing maintenance dialysis. Adv Perit Dial 19:136\u2013142","journal-title":"Adv Perit Dial"},{"key":"1839_CR24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/adc.50.3.238","volume":"50","author":"AE Ford-Jones","year":"1975","unstructured":"Ford-Jones AE, Cogswell JJ (1975) Tests for occult in stools of children. Arch Dis Child 50:238\u2013240","journal-title":"Arch Dis Child"},{"key":"1839_CR25","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2007.06.008","volume":"133","author":"GS Raju","year":"2007","unstructured":"Raju GS, Gerson L, Das A, Lewis B (2007) American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology 133:1694","journal-title":"Gastroenterology"},{"key":"1839_CR26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.2005.078626","volume":"55","author":"L Gatta","year":"2006","unstructured":"Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci V, Vaira D (2006) Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut 55:457\u2013462","journal-title":"Gut"},{"key":"1839_CR27","first-page":"799","volume":"54","author":"I Kyrlagkitsis","year":"2007","unstructured":"Kyrlagkitsis I, Ladas SD, Mallass EG, Raptis S, Mentis A, Delliou E, Zizi-Serbetzoglou A, Elemenoglou I, Antonakopoulos N, Karamanolis DG (2007) Evaluation of a conventional ELISA (Novitec) and a near patient immunochromatographic test (Stick H. pyl) for Helicobacter pylori antigen detection in stool. Hepatogastroenterology 54:799\u2013802","journal-title":"Hepatogastroenterology"},{"key":"1839_CR28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.trstmh.2006.05.012","volume":"101","author":"S Brooker","year":"2007","unstructured":"Brooker S, Jardim-Botelho A, Quinnell RJ, Geiger SM, Caldas IR, Fleming F, Hotez PJ, Correa-Oliveira R, Rodrigues LC, Bethony JM (2007) Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg 101:146\u2013154","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1839_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1525-139x.2000.00044.x","volume":"13","author":"J Bergstr\u00f6m","year":"2000","unstructured":"Bergstr\u00f6m J, Lindholm B, Lacson E Jr, Owen W Jr, Lowrie EG, Glassock RJ, Ikizler TA, Wessels FJ, Moldawer LL, Wanner C, Zimmermann J (2000) What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 13:163\u2013175","journal-title":"Semin Dial"},{"issue":"Suppl 11","key":"1839_CR30","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/ndt\/17.suppl_11.39","volume":"17","author":"IC Macdougall","year":"2002","unstructured":"Macdougall IC, Cooper AC (2002) Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17 [Suppl 11]:S39\u2013S43","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ncpneph0281","volume":"2","author":"C Jacobs","year":"2006","unstructured":"Jacobs C (2006) Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients. Nat Clin Pract Nephrol 2:552\u2013553","journal-title":"Nat Clin Pract Nephrol"},{"key":"1839_CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1525-1594.2002.06888.x","volume":"26","author":"S Sezer","year":"2002","unstructured":"Sezer S, Ozdemir FN, Yakupoglu U, Arat Z, Turan M, Haberal M (2002) Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif Organs 26:366\u2013370","journal-title":"Artif Organs"},{"key":"1839_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000013563","volume":"20","author":"M Gallieni","year":"2000","unstructured":"Gallieni M, Corsi C, Brancaccio D (2000) Hyperparathyroidism and anemia in renal failure. Am J Nephrol 20:89\u201396","journal-title":"Am J Nephrol"},{"key":"1839_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000096143","volume":"16","author":"N Al-Hilali","year":"2007","unstructured":"Al-Hilali N, Al-Humoud H, Ninan VT, Nampoory MR, Puliyclil MA, Johny KV (2007) Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract 16:63\u201367","journal-title":"Med Princ Pract"},{"key":"1839_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000185910","volume":"55","author":"D Meytes","year":"1990","unstructured":"Meytes D, Shacked N, Blum M, Ramot B (1990) Effect of excess parathyroid hormone on human bone marrow fibroblasts. Nephron 55:6\u20139","journal-title":"Nephron"},{"issue":"4","key":"1839_CR36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1159\/000188961","volume":"72","author":"S Nomura","year":"1996","unstructured":"Nomura S, Ogawa Y, Osawa G, Katagiri M, Harada T, Nagahana H (1996) Myelofibrosis secondary to renal osteodystrophy. Nephron 72(4):683\u2013687","journal-title":"Nephron"},{"key":"1839_CR37","doi-asserted-by":"crossref","first-page":"E1670","DOI":"10.1152\/ajpendo.00287.2007","volume":"293","author":"S Brunner","year":"2007","unstructured":"Brunner S, Theiss HD, Murr A, Negele T, Franz WM (2007) Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells. Am J Physiol Endocrinol Metab 293:E1670\u2013E1675","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1839_CR38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.bone.2006.06.010","volume":"39","author":"DJ Rickard","year":"2006","unstructured":"Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME (2006) Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361\u20131372","journal-title":"Bone"},{"key":"1839_CR39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1797.2006.00674.x","volume":"11","author":"CJ Diskin","year":"2006","unstructured":"Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB (2006) Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton) 11:394\u2013399","journal-title":"Nephrology (Carlton)"},{"key":"1839_CR40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.surg.2008.07.026","volume":"144","author":"JA Trunzo","year":"2008","unstructured":"Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM (2008) Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery 144:915\u2013918","journal-title":"Surgery"},{"key":"1839_CR41","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013S201","journal-title":"Am J Kidney Dis"},{"key":"1839_CR42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","volume":"10","author":"B Modell","year":"2008","unstructured":"Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42","journal-title":"J Cardiovasc Magn Reson"},{"key":"1839_CR43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000073439","volume":"21","author":"B Iorio Di","year":"2003","unstructured":"Di Iorio B, Guastaferro P, Bellizzi V (2003) Relationship between resistance to erythropoietin and high anomalous hemoglobin levels in hemodialysis patients with beta-thalassemia minor. Blood Purif 21:376\u2013380","journal-title":"Blood Purif"},{"key":"1839_CR44","first-page":"85","volume":"56","author":"N Das","year":"2004","unstructured":"Das N, Das Chowdhury T, Chattopadhyay A, Datta AG (2004) Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol 56:85\u201396","journal-title":"Pol J Pharmacol"},{"issue":"2","key":"1839_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21307\/immunohematology-2019-234","volume":"25","author":"SD Roseff","year":"2009","unstructured":"Roseff SD (2009) Sickle cell disease: a review. Immunohematology 25(2):67\u201374","journal-title":"Immunohematology"},{"key":"1839_CR46","first-page":"108","volume":"43","author":"T Teuscher","year":"1991","unstructured":"Teuscher T, Baillod B, Holzer BR (1991) Prevalence of human parvovirus B19 in sickle cell disease and healthy controls. Trop Geogr Med 43:108\u2013110","journal-title":"Trop Geogr Med"},{"key":"1839_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","volume":"21","author":"PJ Mason","year":"2007","unstructured":"Mason PJ, Bautista JM, Gilsanz F (2007) G6PD deficiency: the genotype-phenotype association. Blood Rev 21:267\u2013283","journal-title":"Blood Rev"},{"key":"1839_CR48","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00467-005-2021-7","volume":"20","author":"OF Bamgbola","year":"2005","unstructured":"Bamgbola OF, Kaskel F (2005) Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis. Pediatr Nephrol 20:1622\u20131629","journal-title":"Pediatr Nephrol"},{"key":"1839_CR49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00467-008-0954-3","volume":"24","author":"OF Bamgbola","year":"2009","unstructured":"Bamgbola OF, Kaskel FJ, Coco M (2009) Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol 24:571\u2013579","journal-title":"Pediatr Nephrol"},{"key":"1839_CR50","first-page":"187","volume":"3","author":"EW Boeschoten","year":"1988","unstructured":"Boeschoten EW, Schrijver J, Krediet RT, Schreurs WH, Arisz L (1988) Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol Dial Transplant 3:187\u2013193","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR51","first-page":"291","volume":"31","author":"K Phekoo","year":"1979","unstructured":"Phekoo K, Williams Y, Schey SA, Andrews VE, Dudley JM, Hoffbrand AV (1979) Folate assays: serum or red cell? J R Coll Physicians Lond 31:291\u2013295","journal-title":"J R Coll Physicians Lond"},{"key":"1839_CR52","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1177\/15648265080292S108","volume":"29","author":"R Green","year":"2008","unstructured":"Green R (2008) Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull 29:S52\u2013S63","journal-title":"Food Nutr Bull"},{"key":"1839_CR53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0272-6386(95)90064-0","volume":"26","author":"JD Koppel","year":"1995","unstructured":"Koppel JD, Jones MR, Keshavia PR, Bergstrom J, Lindsay RM, Moran J, Nolph KD, Teehan BP (1995) A proposed glossary for dialysis kinetics. Am J Kidney Dis 26:963\u2013981","journal-title":"Am J Kidney Dis"},{"key":"1839_CR54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.1994.12","volume":"45","author":"JC Harty","year":"1994","unstructured":"Harty JC, Boulton H, Curwell J, Heelis N, Uttley L, Venning MC, Gokal R (1994) The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103\u2013109","journal-title":"Kidney Int"},{"key":"1839_CR55","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000168663","volume":"13","author":"JC Harty","year":"1993","unstructured":"Harty JC, Boulton H, Heelis N, Uttley L, Venning M, Gokal R (1993) Limitations of kinetic models as predictors of nutritional and dialysis adequacy in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 13:454\u2013463","journal-title":"Am J Nephrol"},{"key":"1839_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semnephrol.2008.10.008","volume":"29","author":"NJ Cano","year":"2009","unstructured":"Cano NJ, Miolane-Debouit M, L\u00e9ger J, Heng AE (2009) Assessment of body protein: energy status in chronic kidney disease. Semin Nephrol 29:59\u201366","journal-title":"Semin Nephrol"},{"key":"1839_CR57","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/ndt\/14.11.2579","volume":"14","author":"R Perez-Garcia","year":"1999","unstructured":"Perez-Garcia R, Rodriguez-Benitez P (1999) Chloramine, a sneaky contaminant of dialysate. Nephrol Dial Transplant 14:2579\u20132582","journal-title":"Nephrol Dial Transplant"},{"key":"1839_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/089686080602600110","volume":"26","author":"EJ Sharples","year":"2006","unstructured":"Sharples EJ, Varagunam M, Sinnott PJ, McCloskey DJ, Raftery MJ, Yaqoob MM (2006) The effect of proinflammatory cytokine gene and angiotensin-converting enzyme polymorphisms on erythropoietin requirements in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 26:64\u201368","journal-title":"Perit Dial Int"},{"key":"1839_CR59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85\u2013118","journal-title":"Immunopharmacology"},{"key":"1839_CR60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clinthera.2008.04.014","volume":"30","author":"DR Kuypers","year":"2008","unstructured":"Kuypers DR, de Jonge H, Naesens M, de Loor H, Halewijck E, Dekens M, Vanrenterghem Y (2008) Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients. Clin Ther 30:673\u2013683","journal-title":"Clin Ther"},{"issue":"S2","key":"1839_CR61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ndt\/17.suppl_2.21","volume":"17","author":"HH Malluche","year":"2002","unstructured":"Malluche HH (2002) Aluminum and bone disease in chronic renal failure. Nephrol Dial Transplant 17(S2):21\u201324","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1839_CR62","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0272-6386(85)80092-5","volume":"6","author":"KA Schwartz","year":"1985","unstructured":"Schwartz KA (1985) Aluminum-induced anemia. Am J Kidney Dis 6(5):348\u2013352","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1839_CR63","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1542\/peds.2007-3608","volume":"123","author":"RL Jones","year":"2009","unstructured":"Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ (2009) Trends in blood lead levels and blood lead testing among US children aged 1 to 5\u00a0years, 1988\u20132004. Pediatrics 123(3):e376\u2013e385","journal-title":"Pediatrics"},{"issue":"1","key":"1839_CR64","first-page":"2","volume":"11","author":"L Patrick","year":"2006","unstructured":"Patrick L (2006) Lead toxicity, a review of the literature. I. Exposure, evaluation, and treatment. Altern Med Rev 11(1):2\u201322","journal-title":"Altern Med Rev"},{"issue":"5","key":"1839_CR65","first-page":"979","volume":"67","author":"RC Oh","year":"2003","unstructured":"Oh RC, Brown DL (2003) Vitamin B12 deficiency. Am Fam Physician 67(5):979\u2013986","journal-title":"Am Fam Physician"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1839-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-011-1839-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-1839-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T14:04:23Z","timestamp":1637417063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-011-1839-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,20]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1007\/s00467-011-1839-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,20]]}}}